Journal
/
/
Tumor Behandling Field Therapy sammen med bevacizumab til behandling af recidiverende glioblastoma
JoVE Journal
Medicine
This content is Free Access.
JoVE Journal Medicine
Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
DOI:

06:15 min

October 27, 2014

Chapters

  • 00:05Title
  • 01:35Assembling the Tumor Treating Fields System
  • 02:49Applying the Transducer Arrays to the Scalp
  • 04:11Results: Patient Treated with Tumor Treating Field Therapy with Bevacizumab
  • 05:34Conclusion

Summary

Automatic Translation

En hidtil ukendt metode, der anvendes til behandling af recidiverende glioblastomer beskrives. Denne behandling tilgang beskæftiger anvendelsen af ​​vekslende elektrisk tumor behandling felter (TTFields), kendt som TTF Therapy i kombination med bevacizumab, et målrettet middel, der er i øjeblikket FDA godkendt som monoterapi.

Related Videos

Read Article